Advanced search
Publication Cover
International Journal of Nanomedicine Volume 12, 2017 - Issue
Submit an article Journal homepage
116
Views
39
CrossRef citations to date
0
Altmetric
Original Research

Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac

Thangirala Sudha1 The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA
,
Dhruba J Bharali1 The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA
,
Murat Yalcin1 The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA;2 Department of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle, Bursa, Turkey
,
Noureldien HE Darwish1 The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA;3 Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
,
Melis Debreli Coskun1 The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA;4 Department of Biology, Faculty of Arts and Sciences, Uludag University, Gorukle, Bursa, Turkey
,
Kelly A Keating1 The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA
,
Hung-Yun Lin5 PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology;6 Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
,
Paul J Davis1 The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA;7 Department of Medicine, Albany Medical College, Albany, NY, USA
&
Shaker A Mousa1 The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USACorrespondence[email protected]
 show all
Pages 1305-1315 | Published online: 15 Feb 2017

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ying Wang, Ke Zheng, Guangshan Xuan, Mingdong Huang & Jinping Xue. (2018) Novel pH-sensitive zinc phthalocyanine assembled with albumin for tumor targeting and treatment. International Journal of Nanomedicine 13, pages 7681-7695.
Read now
Mona Alibolandi, Sara Amel Farzad, Marzieh Mohammadi, Khalil Abnous, Seyed Mohammad Taghdisi, Fatemeh Kalalinia & Mohammad Ramezani. (2018) Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 1003-1014.
Read now

Articles from other publishers (37)

Delaram Kargari Aghmiouni & Sepideh Khoee. (2023) Dual-Drug Delivery by Anisotropic and Uniform Hybrid Nanostructures: A Comparative Study of the Function and Substrate–Drug Interaction Properties. Pharmaceutics 15:4, pages 1214.
Crossref
Fatima Redah Alassaif, Eman Redah Alassaif, Amit Kumar Kaushik & Jeevitha Dhanapal. (2023) Enhanced Anti-Proliferative Effect of Carboplatin in Ovarian Cancer Cells Exploiting Chitosan-Poly (Lactic Glycolic Acid) Nanoparticles. Recent Patents on Nanotechnology 17:1, pages 74-82.
Crossref
Amir R. Afshari, Mehdi Sanati, Hamid Mollazadeh, Prashant Kesharwani, Thomas P. Johnston & Amirhossein Sahebkar. (2022) Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways. Seminars in Cancer Biology 86, pages 860-872.
Crossref
Jinrong He, Peng Zheng, Yongjun Chen, Jialong Qi, Chao Ye, Duo Li, Ying Yang, Ying Yang, Qingwen Liu, Yongmao Hu, Xiao Zheng, Weiran Li, Liangqun Hua, Zhongqian Yang, Haoqian Chen, Weiwei Huang, Wenjia Sun, Xu Yang, Qiong Long, Hongmei Bai & Yanbing Ma. (2022) A new personalized vaccine strategy based on inducing the pyroptosis of tumor cells in vivo by transgenic expression of a truncated GSDMD N-terminus. Frontiers in Immunology 13.
Crossref
Taher A. Salaheldin, Vaqar M. Adhami, Kazutoshi Fujioka, Hasan Mukhtar & Shaker A. Mousa. (2022) Photochemoprevention of ultraviolet Beam Radiation-induced DNA damage in keratinocytes by topical delivery of nanoformulated Epigallocatechin-3-gallate. Nanomedicine: Nanotechnology, Biology and Medicine 44, pages 102580.
Crossref
Anjul Khadria & Subhankar Paul. (2022) Formation of Stable Cruciform Assembly of Gold Nanoparticles from Cannabis indica Leaves. Applied Nano 3:3, pages 143-148.
Crossref
Hojoon Lee, Min Ah Kim, Jung-Sick Lee & Chang-Moon Lee. (2022) C-Phycoycanin-Doxorubicin Nanoparticles for Chemo-Photodynamic Cancer Therapy. Macromolecular Research 30:7, pages 486-494.
Crossref
Nardeen Perko & Shaker A. Mousa. (2022) Management of Pancreatic Cancer and Its Microenvironment: Potential Impact of Nano-Targeting. Cancers 14:12, pages 2879.
Crossref
Taher A. Salaheldin, Kavitha Godugu, Dhruba J. Bharali, Kazutoshi Fujioka, Nabil Elshourbagy & Shaker A. Mousa. (2022) Novel oral nano-hepatic targeted anti-PCSK9 in hypercholesterolemia. Nanomedicine: Nanotechnology, Biology and Medicine 40, pages 102480.
Crossref
Michelle K. Greene, Michael C. Johnston & Christopher J. Scott. (2021) Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance. Cancers 13:24, pages 6175.
Crossref
Ozlem Karakus, Noureldien Darwish, Thangirala Sudha, Taher Salaheldin, Kazutoshi Fujioka, Peter Dickinson, Brian Weil & Shaker Mousa. (2021) Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult. Biomedicines 9:11, pages 1713.
Crossref
Pooja Jain, Himanshu Kathuria & Munira Momin. (2021) Clinical therapies and nano drug delivery systems for urinary bladder cancer. Pharmacology & Therapeutics 226, pages 107871.
Crossref
Rehan Uddin, Noureldian H. E. Darwish & Shaker A. Mousa. (2021) Acute Myeloid Leukemia Mutations and Future Mechanistic Target to Overcome Resistance. Current Treatment Options in Oncology 22:9.
Crossref
Ali H. El-Far, Kavitha Godugu, Taher A. Salaheldin, Noureldien H. E. Darwish, Amna A. Saddiq & Shaker A. Mousa. (2021) Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines 9:8, pages 990.
Crossref
Tsai-Mu Cheng, Wong-Jin Chang, Hsiu-Yi Chu, Roberto De Luca, Jens Z. Pedersen, Sandra Incerpi, Zi-Lin Li, Ya-Jung Shih, Hung-Yun Lin, Kuan Wang & Jacqueline Whang-Peng. (2021) Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy. Cells 10:7, pages 1684.
Crossref
Ali H El-Far, Taher A Salaheldin, Kavitha Godugu, Noureldien HE Darwish & Shaker A Mousa. (2021) Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity. Nanomedicine 16:17, pages 1457-1469.
Crossref
Rami Alzhrani, Hashem O. Alsaab, Kushal Vanamala, Ketki Bhise, Katyayani Tatiparti, Ayatakshi Barari, Samaresh Sau & Arun K. Iyer. (2021) Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes. Advanced Therapeutics 4:6, pages 2000262.
Crossref
Shaker Mousa. (2021) Impact of Nanotechnology on the Future of Pharmaceuticals and Nutraceuticals: The Road toward Precision Medicines—Case Studies. Impact of Nanotechnology on the Future of Pharmaceuticals and Nutraceuticals: The Road toward Precision Medicines—Case Studies.
Paul J. DavisShaker A. MousaHung-Yun Lin. (2021) Nongenomic Actions of Thyroid Hormone: The Integrin Component. Physiological Reviews 101:1, pages 319-352.
Crossref
Shaker A. Mousa & Paul J. Davis. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 174 181 .
Lavinia Salama, Elizabeth R. Pastor, Tyler Stone & Shaker A. Mousa. (2020) Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management. Biomedicines 8:9, pages 347.
Crossref
Yang Xing, Ying Zhou, Yan Zhang, Caihong Zhang, Xu Deng, Chuan Dong & Shaomin Shuang. (2020) Facile Fabrication Route of Janus Gold-Mesoporous Silica Nanocarriers with Dual-Drug Delivery for Tumor Therapy. ACS Biomaterials Science & Engineering 6:3, pages 1573-1581.
Crossref
Melis Debreli Coskun, Thangirala Sudha, Dhruba J. Bharali, Serap Celikler, Paul J. Davis & Shaker A. Mousa. (2020) αvβ3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model. Frontiers in Pharmacology 11.
Crossref
Yajie Zhang, Miguel García-Gabilondo, Alba Grayston, Irene V. J. Feiner, Irene Anton-Sales, Rodrigo A. Loiola, Jordi Llop, Pedro Ramos-Cabrer, Ignasi Barba, David Garcia-Dorado, Fabien Gosselet, Anna Rosell & Anna Roig. (2020) PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities. Nanoscale 12:8, pages 4988-5002.
Crossref
Tianqi Su, Bo Yang, Tianren Gao, Tongjun Liu & Jiannan Li. (2020) Polymer nanoparticle-assisted chemotherapy of pancreatic cancer. Therapeutic Advances in Medical Oncology 12, pages 175883592091597.
Crossref
Shaheedul A. Sami, Noureldien H. E. Darwish, Amanda N. M. Barile & Shaker A. Mousa. (2020) Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy. Current Treatment Options in Oncology 21:1.
Crossref
Shaker A. Mousa & Paul J. Davis. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1 8 .
Mehdi Rajabi, Kavitha Godugu, Thangirala Sudha, Dhruba J. Bharali & Shaker A. Mousa. (2019) Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α v β 3 Antagonist with Potent Anticancer Activities in Glioblastoma Multiforme . Bioconjugate Chemistry 30:12, pages 3087-3097.
Crossref
Weikun Li, Murat Yalcin, Dhruba J. Bharali, Qishan Lin, Kavitha Godugu, Kazutoshi Fujioka, Kelly A. Keating & Shaker A. Mousa. (2019) Pharmacokinetics, Biodistribution, and Anti-Angiogenesis Efficacy of Diamino Propane Tetraiodothyroacetic Acid-conjugated Biodegradable Polymeric Nanoparticle. Scientific Reports 9:1.
Crossref
Noureldien H. E. Darwish, Thangirala Sudha, Kavitha Godugu, Dhruba J. Bharali, Osama Elbaz, Hasan A. Abd El-ghaffar, Emad Azmy, Nahla Anber & Shaker A. Mousa. (2019) Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia. Molecules 24:11, pages 2103.
Crossref
Yu-Tang Chin, Zong-Rong He, Chi-Long Chen, Hsiao-Ching Chu, Yih Ho, Po-Yu Su, Yu-Chen S. H. Yang, Kuan Wang, Ya-Jung Shih, Yi-Ru Chen, Jens Z. Pedersen, Sandra Incerpi, André Wendindondé Nana, Heng-Yuan Tang, Hung-Yun Lin, Shaker A. Mousa, Paul J. Davis & Jacqueline Whang-Peng. (2019) Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Frontiers in Endocrinology 10.
Crossref
John T. Leith, Shaker A. Mousa, Aleck Hercbergs, Hung-Yun Lin & Paul J. Davis. (2018) Radioresistance of cancer cells, integrin αvβ3 and thyroid hormone. Oncotarget 9:97, pages 37069-37075.
Crossref
Catherine M. Sielaff & Shaker A. Mousa. (2018) Status and future directions in the management of pancreatic cancer: potential impact of nanotechnology. Journal of Cancer Research and Clinical Oncology 144:7, pages 1205-1217.
Crossref
William Grimes, Yangyang Luo, Antwine McFarlandJr.Jr. & David Mills. (2018) Bi-Functionalized Clay Nanotubes for Anti-Cancer Therapy. Applied Sciences 8:2, pages 281.
Crossref
Mona Alibolandi, Rouhollah Rezvani, Sara Amel Farzad, Seyed Mohammad Taghdisi, Khalil Abnous & Mohammad Ramezani. (2017) Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. International Journal of Pharmaceutics 532:1, pages 581-594.
Crossref
Mehdi Rajabi & Shaker Mousa. (2017) The Role of Angiogenesis in Cancer Treatment. Biomedicines 5:4, pages 34.
Crossref
Dhruba J. Bharali, Mehdi Rajabi & Shaker A. Mousa. 2017. Anti-Angiogenesis Strategies in Cancer Therapeutics. Anti-Angiogenesis Strategies in Cancer Therapeutics 165 178 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.